Israeli-founded AI biotech Immunai expands AstraZeneca cancer collaboration

May 7, 2026 | Israel Insider, Ticker

The expanded agreement extends and broadens the companies’ multi-year collaboration in oncology through 2027, according to the statement. | Read More in JPost.com – Tech | The Jerusalem Post   | Read More Israel Insider | NOWlej 

0 Comments

FREE ISRAEL DAILY EMAIL!

BREAKING NEWS

JNS